Webinar on Clinical Trials During the Corona Virus Pandemic: Pragmatic Approach to the Risks
Our risk management plans for clinical trials foresee electricity breakdowns, flooding, fire, etc. but do they foresee a pandemic?
|Date(s)||06 Apr. 2020|
|Day(s)||17:00 - 18:30|
|Duration||1 hour 30|
Our risk management plans for clinical trials foresee electricity breakdowns, flooding, fire, etc. but do they foresee a pandemic? If not then quick risk assessment adaptations and pragmatic solution finding are essential to protect your patients and the clinical trial objectives. National and international competent authorities release guidance on how to handle clinical trials in the current crisis situation but the proposals are very heterogenous. How to find the best solutions for YOUR patients in YOUR clinical trial?
Hear the recommendations from our EFGCP quality and ethics experts, discuss with us and ask your questions.
Introduction to the Webinar & Moderation, Needs to Manage a Disaste
Moderator(s): Mark Poulton, Poulton Quality Solutions
Risks to the study concerning the quality oversight in the trial from site and sponsor perspective
Cathy Dove, Dove Quality Solutions
Claire Khalil, Evelo Biosciences
Heather Sampson, University of Toronto
Global sponsor perspective and present pragmatic options (with caveats) for sponsors
Seifeddine Amara Madi, GSK
End of the Webinar